SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-15 |
| Reported value | $9,586,027,944 |
| Positions | 82 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| NUVALENT INC | NUVL | COM | $2,130,183,575 | 17,248,450 |
| BROOKDALE SR LIVING INC | Unresolved | NOTE 3.500%10/1 | $585,704,753 | 306,885,000 |
| REVOLUTION MEDICINES INC | RVMD | COM | $447,973,760 | 2,392,000 |
| PRAXIS PRECISION MEDICINES I | PRAX | COM NEW | $322,520,281 | 963,351 |
| VIATRIS INC | VTRS | COM | $320,873,980 | 20,206,170 |
| CENTENE CORP DEL | CNC | COM | $314,595,190 | 4,901,000 |
| REVOLUTION MEDICINES INC | Unresolved | NOTE 0.500% 5/0 | $251,681,000 | 200,000,000 |
| UNITED THERAPEUTICS CORP DEL | UTHR | COM | $247,616,310 | 457,000 |
| ARROWHEAD PHARMACEUTICALS IN | ARWR | NOTE 1/1 | $240,537,600 | 200,000,000 |
| LEGEND BIOTECH CORP | LEGN | SPONSORED ADS | $235,014,985 | 8,137,638 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.